Harrow Health, Inc.

Total Valuation

Harrow Health, Inc. carries a market capitalization of 1.24B, placing it among publicly traded companies globally. Its enterprise value stands at 1.51B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Harrow Health, Inc. currently has 37.27M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 4.86, and the price-to-book ratio stands at -7.09.

Enterprise Valuation

On an enterprise value basis, Harrow Health, Inc. trades at an EV/EBITDA multiple of 37.55 and an EV/FCF ratio of 23.13. The EV/Sales ratio of 5.62 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 76.78 provides insight into valuation relative to core operating earnings.

Financial Position

Harrow Health, Inc. maintains a current ratio of 2.48, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1,060.52, indicating moderate leverage, while an interest coverage ratio of 1.74 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, Harrow Health, Inc. has paid 3.80M in income taxes, reflecting an effective tax rate of 36.27.

Stock Price Statistics

Harrow Health, Inc.'s stock has gained approximately 13.5651% over the past 52 weeks. The 50-day moving average sits at 36.27, while the 200-day moving average is 41.29.

Income Statement

Over the trailing twelve months, Harrow Health, Inc. generated 268.68M in revenue and converted that into -14.96M in net income, yielding earnings per share of -0.39. EBITDA reached 40.21M, while operating income came in at 19.67M.

Balance Sheet

Harrow Health, Inc. holds 94.64M in cash and equivalents against 300.67M in total debt, resulting in a net debt position of 197.44M. Total book value stands at -184.09M, with working capital of 134.95M providing operational flexibility.

Cash Flow

Harrow Health, Inc. produced 15.20M in operating cash flow over the past twelve months. After subtracting -19.09M in capital expenditures, free cash flow totaled -3.89M - equivalent to -0.11 per share.

Margins

Harrow Health, Inc. operates with a gross margin of 74.11, reflecting its pricing power and cost economics. The operating margin of 7.32 and net profit margin of -5.57 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Harrow Health, Inc.'s most recent stock split took place on February 8, 2013 with a 5:1 split ratio.

Scores

Harrow Health, Inc. posts an Altman Z-Score of 3.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.